Antitumor activity of pemetrexed (Pem) in second-line advanced/metastatic osteosarcomas: A multicenter phase II study. Background: Patients treated with limb salvage surgery for bone sarcomas of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results